Global Targeted Psma Radionuclide Drug Conjugates Market Research Report 2026(Status and Outlook)
Targeted PSMA radionuclide drug conjugates are innovative therapeutic agents designed to treat prostate cancer by combining a radioactive isotope with a ligand that specifically binds to prostate-specific membrane antigen (PSMA). This targeted approach allows for the precise delivery of radiation directly to cancer cells, enhancing the effectiveness of treatment while minimizing damage to surrounding healthy tissue.
The global Targeted Psma Radionuclide Drug Conjugates market size was estimated at USD 850.25 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Targeted Psma Radionuclide Drug Conjugates market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Targeted Psma Radionuclide Drug Conjugates market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Targeted Psma Radionuclide Drug Conjugates market.
Global Targeted Psma Radionuclide Drug Conjugates Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Telix Pharmaceutical
Lantheus
University of California
Grand Pharmaceutical
Market Segmentation (by Type)
Diagnostic
Therapeutic
Market Segmentation (by Application)
Hospital
Specialist Clinic
Other
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Targeted Psma Radionuclide Drug Conjugates Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Targeted Psma Radionuclide Drug Conjugates, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Targeted Psma Radionuclide Drug Conjugates market size was estimated at USD 850.25 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Targeted Psma Radionuclide Drug Conjugates market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Targeted Psma Radionuclide Drug Conjugates market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Targeted Psma Radionuclide Drug Conjugates market.
Global Targeted Psma Radionuclide Drug Conjugates Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Telix Pharmaceutical
Lantheus
University of California
Grand Pharmaceutical
Market Segmentation (by Type)
Diagnostic
Therapeutic
Market Segmentation (by Application)
Hospital
Specialist Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Targeted Psma Radionuclide Drug Conjugates Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Targeted Psma Radionuclide Drug Conjugates Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Targeted Psma Radionuclide Drug Conjugates, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Targeted Psma Radionuclide Drug Conjugates
1.2 Key Market Segments
1.2.1 Targeted Psma Radionuclide Drug Conjugates Segment by Type
1.2.2 Targeted Psma Radionuclide Drug Conjugates Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Targeted Psma Radionuclide Drug Conjugates Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Targeted Psma Radionuclide Drug Conjugates Product Life Cycle
3.3 Global Targeted Psma Radionuclide Drug Conjugates Sales by Manufacturers (2020-2025)
3.4 Global Targeted Psma Radionuclide Drug Conjugates Revenue Market Share by Manufacturers (2020-2025)
3.5 Targeted Psma Radionuclide Drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Targeted Psma Radionuclide Drug Conjugates Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Targeted Psma Radionuclide Drug Conjugates Market Competitive Situation and Trends
3.8.1 Targeted Psma Radionuclide Drug Conjugates Market Concentration Rate
3.8.2 Global 5 and 10 Largest Targeted Psma Radionuclide Drug Conjugates Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES INDUSTRY CHAIN ANALYSIS
4.1 Targeted Psma Radionuclide Drug Conjugates Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Targeted Psma Radionuclide Drug Conjugates Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Targeted Psma Radionuclide Drug Conjugates Market
5.7 ESG Ratings of Leading Companies
6 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Type (2020-2025)
6.3 Global Targeted Psma Radionuclide Drug Conjugates Market Size by Type (2020-2025)
6.4 Global Targeted Psma Radionuclide Drug Conjugates Price by Type (2020-2025)
7 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Targeted Psma Radionuclide Drug Conjugates Market Sales by Application (2020-2025)
7.3 Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) by Application (2020-2025)
7.4 Global Targeted Psma Radionuclide Drug Conjugates Sales Growth Rate by Application (2020-2025)
8 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET SALES BY REGION
8.1 Global Targeted Psma Radionuclide Drug Conjugates Sales by Region
8.1.1 Global Targeted Psma Radionuclide Drug Conjugates Sales by Region
8.1.2 Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Region
8.2 Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region
8.2.1 Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region
8.2.2 Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region
8.3 North America
8.3.1 North America Targeted Psma Radionuclide Drug Conjugates Sales by Country
8.3.2 North America Targeted Psma Radionuclide Drug Conjugates Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Targeted Psma Radionuclide Drug Conjugates Sales by Country
8.4.2 Europe Targeted Psma Radionuclide Drug Conjugates Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Targeted Psma Radionuclide Drug Conjugates Sales by Region
8.5.2 Asia Pacific Targeted Psma Radionuclide Drug Conjugates Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Targeted Psma Radionuclide Drug Conjugates Sales by Country
8.6.2 South America Targeted Psma Radionuclide Drug Conjugates Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Sales by Region
8.7.2 Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET PRODUCTION BY REGION
9.1 Global Production of Targeted Psma Radionuclide Drug Conjugates by Region(2020-2025)
9.2 Global Targeted Psma Radionuclide Drug Conjugates Revenue Market Share by Region (2020-2025)
9.3 Global Targeted Psma Radionuclide Drug Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Targeted Psma Radionuclide Drug Conjugates Production
9.4.1 North America Targeted Psma Radionuclide Drug Conjugates Production Growth Rate (2020-2025)
9.4.2 North America Targeted Psma Radionuclide Drug Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Targeted Psma Radionuclide Drug Conjugates Production
9.5.1 Europe Targeted Psma Radionuclide Drug Conjugates Production Growth Rate (2020-2025)
9.5.2 Europe Targeted Psma Radionuclide Drug Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Targeted Psma Radionuclide Drug Conjugates Production (2020-2025)
9.6.1 Japan Targeted Psma Radionuclide Drug Conjugates Production Growth Rate (2020-2025)
9.6.2 Japan Targeted Psma Radionuclide Drug Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Targeted Psma Radionuclide Drug Conjugates Production (2020-2025)
9.7.1 China Targeted Psma Radionuclide Drug Conjugates Production Growth Rate (2020-2025)
9.7.2 China Targeted Psma Radionuclide Drug Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Targeted Psma Radionuclide Drug Conjugates Product Overview
10.1.3 Novartis Targeted Psma Radionuclide Drug Conjugates Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Telix Pharmaceutical
10.2.1 Telix Pharmaceutical Basic Information
10.2.2 Telix Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Overview
10.2.3 Telix Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Market Performance
10.2.4 Telix Pharmaceutical Business Overview
10.2.5 Telix Pharmaceutical SWOT Analysis
10.2.6 Telix Pharmaceutical Recent Developments
10.3 Lantheus
10.3.1 Lantheus Basic Information
10.3.2 Lantheus Targeted Psma Radionuclide Drug Conjugates Product Overview
10.3.3 Lantheus Targeted Psma Radionuclide Drug Conjugates Product Market Performance
10.3.4 Lantheus Business Overview
10.3.5 Lantheus SWOT Analysis
10.3.6 Lantheus Recent Developments
10.4 University of California
10.4.1 University of California Basic Information
10.4.2 University of California Targeted Psma Radionuclide Drug Conjugates Product Overview
10.4.3 University of California Targeted Psma Radionuclide Drug Conjugates Product Market Performance
10.4.4 University of California Business Overview
10.4.5 University of California Recent Developments
10.5 Grand Pharmaceutical
10.5.1 Grand Pharmaceutical Basic Information
10.5.2 Grand Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Overview
10.5.3 Grand Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Market Performance
10.5.4 Grand Pharmaceutical Business Overview
10.5.5 Grand Pharmaceutical Recent Developments
11 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET FORECAST BY REGION
11.1 Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast
11.2 Global Targeted Psma Radionuclide Drug Conjugates Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country
11.2.3 Asia Pacific Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Region
11.2.4 South America Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Targeted Psma Radionuclide Drug Conjugates by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Targeted Psma Radionuclide Drug Conjugates Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Targeted Psma Radionuclide Drug Conjugates by Type (2026-2035)
12.1.2 Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Targeted Psma Radionuclide Drug Conjugates by Type (2026-2035)
12.2 Global Targeted Psma Radionuclide Drug Conjugates Market Forecast by Application (2026-2035)
12.2.1 Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) Forecast by Application
12.2.2 Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Targeted Psma Radionuclide Drug Conjugates
1.2 Key Market Segments
1.2.1 Targeted Psma Radionuclide Drug Conjugates Segment by Type
1.2.2 Targeted Psma Radionuclide Drug Conjugates Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Targeted Psma Radionuclide Drug Conjugates Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Targeted Psma Radionuclide Drug Conjugates Product Life Cycle
3.3 Global Targeted Psma Radionuclide Drug Conjugates Sales by Manufacturers (2020-2025)
3.4 Global Targeted Psma Radionuclide Drug Conjugates Revenue Market Share by Manufacturers (2020-2025)
3.5 Targeted Psma Radionuclide Drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Targeted Psma Radionuclide Drug Conjugates Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Targeted Psma Radionuclide Drug Conjugates Market Competitive Situation and Trends
3.8.1 Targeted Psma Radionuclide Drug Conjugates Market Concentration Rate
3.8.2 Global 5 and 10 Largest Targeted Psma Radionuclide Drug Conjugates Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES INDUSTRY CHAIN ANALYSIS
4.1 Targeted Psma Radionuclide Drug Conjugates Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Targeted Psma Radionuclide Drug Conjugates Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Targeted Psma Radionuclide Drug Conjugates Market
5.7 ESG Ratings of Leading Companies
6 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Type (2020-2025)
6.3 Global Targeted Psma Radionuclide Drug Conjugates Market Size by Type (2020-2025)
6.4 Global Targeted Psma Radionuclide Drug Conjugates Price by Type (2020-2025)
7 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Targeted Psma Radionuclide Drug Conjugates Market Sales by Application (2020-2025)
7.3 Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) by Application (2020-2025)
7.4 Global Targeted Psma Radionuclide Drug Conjugates Sales Growth Rate by Application (2020-2025)
8 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET SALES BY REGION
8.1 Global Targeted Psma Radionuclide Drug Conjugates Sales by Region
8.1.1 Global Targeted Psma Radionuclide Drug Conjugates Sales by Region
8.1.2 Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Region
8.2 Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region
8.2.1 Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region
8.2.2 Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region
8.3 North America
8.3.1 North America Targeted Psma Radionuclide Drug Conjugates Sales by Country
8.3.2 North America Targeted Psma Radionuclide Drug Conjugates Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Targeted Psma Radionuclide Drug Conjugates Sales by Country
8.4.2 Europe Targeted Psma Radionuclide Drug Conjugates Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Targeted Psma Radionuclide Drug Conjugates Sales by Region
8.5.2 Asia Pacific Targeted Psma Radionuclide Drug Conjugates Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Targeted Psma Radionuclide Drug Conjugates Sales by Country
8.6.2 South America Targeted Psma Radionuclide Drug Conjugates Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Sales by Region
8.7.2 Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET PRODUCTION BY REGION
9.1 Global Production of Targeted Psma Radionuclide Drug Conjugates by Region(2020-2025)
9.2 Global Targeted Psma Radionuclide Drug Conjugates Revenue Market Share by Region (2020-2025)
9.3 Global Targeted Psma Radionuclide Drug Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Targeted Psma Radionuclide Drug Conjugates Production
9.4.1 North America Targeted Psma Radionuclide Drug Conjugates Production Growth Rate (2020-2025)
9.4.2 North America Targeted Psma Radionuclide Drug Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Targeted Psma Radionuclide Drug Conjugates Production
9.5.1 Europe Targeted Psma Radionuclide Drug Conjugates Production Growth Rate (2020-2025)
9.5.2 Europe Targeted Psma Radionuclide Drug Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Targeted Psma Radionuclide Drug Conjugates Production (2020-2025)
9.6.1 Japan Targeted Psma Radionuclide Drug Conjugates Production Growth Rate (2020-2025)
9.6.2 Japan Targeted Psma Radionuclide Drug Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Targeted Psma Radionuclide Drug Conjugates Production (2020-2025)
9.7.1 China Targeted Psma Radionuclide Drug Conjugates Production Growth Rate (2020-2025)
9.7.2 China Targeted Psma Radionuclide Drug Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Targeted Psma Radionuclide Drug Conjugates Product Overview
10.1.3 Novartis Targeted Psma Radionuclide Drug Conjugates Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Telix Pharmaceutical
10.2.1 Telix Pharmaceutical Basic Information
10.2.2 Telix Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Overview
10.2.3 Telix Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Market Performance
10.2.4 Telix Pharmaceutical Business Overview
10.2.5 Telix Pharmaceutical SWOT Analysis
10.2.6 Telix Pharmaceutical Recent Developments
10.3 Lantheus
10.3.1 Lantheus Basic Information
10.3.2 Lantheus Targeted Psma Radionuclide Drug Conjugates Product Overview
10.3.3 Lantheus Targeted Psma Radionuclide Drug Conjugates Product Market Performance
10.3.4 Lantheus Business Overview
10.3.5 Lantheus SWOT Analysis
10.3.6 Lantheus Recent Developments
10.4 University of California
10.4.1 University of California Basic Information
10.4.2 University of California Targeted Psma Radionuclide Drug Conjugates Product Overview
10.4.3 University of California Targeted Psma Radionuclide Drug Conjugates Product Market Performance
10.4.4 University of California Business Overview
10.4.5 University of California Recent Developments
10.5 Grand Pharmaceutical
10.5.1 Grand Pharmaceutical Basic Information
10.5.2 Grand Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Overview
10.5.3 Grand Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Market Performance
10.5.4 Grand Pharmaceutical Business Overview
10.5.5 Grand Pharmaceutical Recent Developments
11 TARGETED PSMA RADIONUCLIDE DRUG CONJUGATES MARKET FORECAST BY REGION
11.1 Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast
11.2 Global Targeted Psma Radionuclide Drug Conjugates Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country
11.2.3 Asia Pacific Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Region
11.2.4 South America Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Targeted Psma Radionuclide Drug Conjugates by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Targeted Psma Radionuclide Drug Conjugates Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Targeted Psma Radionuclide Drug Conjugates by Type (2026-2035)
12.1.2 Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Targeted Psma Radionuclide Drug Conjugates by Type (2026-2035)
12.2 Global Targeted Psma Radionuclide Drug Conjugates Market Forecast by Application (2026-2035)
12.2.1 Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) Forecast by Application
12.2.2 Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Type (M USD)
Table 4. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Application
Table 5. Targeted Psma Radionuclide Drug Conjugates Market Size Comparison by Region (M USD)
Table 6. Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Targeted Psma Radionuclide Drug Conjugates Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Targeted Psma Radionuclide Drug Conjugates Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Psma Radionuclide Drug Conjugates as of 2025)
Table 11. Global Market Targeted Psma Radionuclide Drug Conjugates Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Targeted Psma Radionuclide Drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Targeted Psma Radionuclide Drug Conjugates Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Targeted Psma Radionuclide Drug Conjugates Sales by Type (K MT)
Table 27. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Type (M USD)
Table 28. Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) by Type (2020-2025)
Table 29. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Type (2020-2025)
Table 30. Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) by Type (2020-2025)
Table 31. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Type (2020-2025)
Table 32. Global Targeted Psma Radionuclide Drug Conjugates Price (USD/KG) by Type (2020-2025)
Table 33. Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) by Application
Table 34. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Application
Table 35. Global Targeted Psma Radionuclide Drug Conjugates Sales by Application (2020-2025) & (K MT)
Table 36. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Application (2020-2025)
Table 37. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Application (2020-2025) & (M USD)
Table 38. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Application (2020-2025)
Table 39. Global Targeted Psma Radionuclide Drug Conjugates Sales Growth Rate by Application (2020-2025)
Table 40. Global Targeted Psma Radionuclide Drug Conjugates Sales by Region (2020-2025) & (K MT)
Table 41. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Region (2020-2025)
Table 42. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region (2020-2025) & (M USD)
Table 43. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region (2020-2025)
Table 44. North America Targeted Psma Radionuclide Drug Conjugates Sales by Country (2020-2025) & (K MT)
Table 45. North America Targeted Psma Radionuclide Drug Conjugates Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Targeted Psma Radionuclide Drug Conjugates Sales by Country (2020-2025) & (K MT)
Table 47. Europe Targeted Psma Radionuclide Drug Conjugates Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Market Size by Region (2020-2025) & (M USD)
Table 50. South America Targeted Psma Radionuclide Drug Conjugates Sales by Country (2020-2025) & (K MT)
Table 51. South America Targeted Psma Radionuclide Drug Conjugates Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Market Size by Region (2020-2025) & (M USD)
Table 54. Global Targeted Psma Radionuclide Drug Conjugates Production (K MT) by Region(2020-2025)
Table 55. Global Targeted Psma Radionuclide Drug Conjugates Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Targeted Psma Radionuclide Drug Conjugates Revenue Market Share by Region (2020-2025)
Table 57. Global Targeted Psma Radionuclide Drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Targeted Psma Radionuclide Drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Targeted Psma Radionuclide Drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Targeted Psma Radionuclide Drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Targeted Psma Radionuclide Drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis Targeted Psma Radionuclide Drug Conjugates Product Overview
Table 64. Novartis Targeted Psma Radionuclide Drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Telix Pharmaceutical Basic Information
Table 69. Telix Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Overview
Table 70. Telix Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Telix Pharmaceutical Business Overview
Table 72. Telix Pharmaceutical SWOT Analysis
Table 73. Telix Pharmaceutical Recent Developments
Table 74. Lantheus Basic Information
Table 75. Lantheus Targeted Psma Radionuclide Drug Conjugates Product Overview
Table 76. Lantheus Targeted Psma Radionuclide Drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Lantheus Business Overview
Table 78. Lantheus SWOT Analysis
Table 79. Lantheus Recent Developments
Table 80. University of California Basic Information
Table 81. University of California Targeted Psma Radionuclide Drug Conjugates Product Overview
Table 82. University of California Targeted Psma Radionuclide Drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. University of California Business Overview
Table 84. University of California Recent Developments
Table 85. Grand Pharmaceutical Basic Information
Table 86. Grand Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Overview
Table 87. Grand Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Grand Pharmaceutical Business Overview
Table 89. Grand Pharmaceutical Recent Developments
Table 90. Global Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Region (2026-2035) & (K MT)
Table 91. Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Region (2026-2035) & (M USD)
Table 92. North America Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 93. North America Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Europe Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 95. Europe Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Region (2026-2035) & (K MT)
Table 97. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 99. South America Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Country (2026-2035) & (Units)
Table 101. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Global Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Type (2026-2035) & (K MT)
Table 103. Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Type (2026-2035) & (M USD)
Table 104. Global Targeted Psma Radionuclide Drug Conjugates Price Forecast by Type (2026-2035) & (USD/KG)
Table 105. Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) Forecast by Application (2026-2035)
Table 106. Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Type (M USD)
Table 4. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Application
Table 5. Targeted Psma Radionuclide Drug Conjugates Market Size Comparison by Region (M USD)
Table 6. Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Targeted Psma Radionuclide Drug Conjugates Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Targeted Psma Radionuclide Drug Conjugates Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Psma Radionuclide Drug Conjugates as of 2025)
Table 11. Global Market Targeted Psma Radionuclide Drug Conjugates Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Targeted Psma Radionuclide Drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Targeted Psma Radionuclide Drug Conjugates Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Targeted Psma Radionuclide Drug Conjugates Sales by Type (K MT)
Table 27. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Type (M USD)
Table 28. Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) by Type (2020-2025)
Table 29. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Type (2020-2025)
Table 30. Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) by Type (2020-2025)
Table 31. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Type (2020-2025)
Table 32. Global Targeted Psma Radionuclide Drug Conjugates Price (USD/KG) by Type (2020-2025)
Table 33. Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) by Application
Table 34. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Application
Table 35. Global Targeted Psma Radionuclide Drug Conjugates Sales by Application (2020-2025) & (K MT)
Table 36. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Application (2020-2025)
Table 37. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Application (2020-2025) & (M USD)
Table 38. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Application (2020-2025)
Table 39. Global Targeted Psma Radionuclide Drug Conjugates Sales Growth Rate by Application (2020-2025)
Table 40. Global Targeted Psma Radionuclide Drug Conjugates Sales by Region (2020-2025) & (K MT)
Table 41. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Region (2020-2025)
Table 42. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region (2020-2025) & (M USD)
Table 43. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region (2020-2025)
Table 44. North America Targeted Psma Radionuclide Drug Conjugates Sales by Country (2020-2025) & (K MT)
Table 45. North America Targeted Psma Radionuclide Drug Conjugates Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Targeted Psma Radionuclide Drug Conjugates Sales by Country (2020-2025) & (K MT)
Table 47. Europe Targeted Psma Radionuclide Drug Conjugates Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Market Size by Region (2020-2025) & (M USD)
Table 50. South America Targeted Psma Radionuclide Drug Conjugates Sales by Country (2020-2025) & (K MT)
Table 51. South America Targeted Psma Radionuclide Drug Conjugates Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Market Size by Region (2020-2025) & (M USD)
Table 54. Global Targeted Psma Radionuclide Drug Conjugates Production (K MT) by Region(2020-2025)
Table 55. Global Targeted Psma Radionuclide Drug Conjugates Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Targeted Psma Radionuclide Drug Conjugates Revenue Market Share by Region (2020-2025)
Table 57. Global Targeted Psma Radionuclide Drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Targeted Psma Radionuclide Drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Targeted Psma Radionuclide Drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Targeted Psma Radionuclide Drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Targeted Psma Radionuclide Drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis Targeted Psma Radionuclide Drug Conjugates Product Overview
Table 64. Novartis Targeted Psma Radionuclide Drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Telix Pharmaceutical Basic Information
Table 69. Telix Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Overview
Table 70. Telix Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Telix Pharmaceutical Business Overview
Table 72. Telix Pharmaceutical SWOT Analysis
Table 73. Telix Pharmaceutical Recent Developments
Table 74. Lantheus Basic Information
Table 75. Lantheus Targeted Psma Radionuclide Drug Conjugates Product Overview
Table 76. Lantheus Targeted Psma Radionuclide Drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Lantheus Business Overview
Table 78. Lantheus SWOT Analysis
Table 79. Lantheus Recent Developments
Table 80. University of California Basic Information
Table 81. University of California Targeted Psma Radionuclide Drug Conjugates Product Overview
Table 82. University of California Targeted Psma Radionuclide Drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. University of California Business Overview
Table 84. University of California Recent Developments
Table 85. Grand Pharmaceutical Basic Information
Table 86. Grand Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Product Overview
Table 87. Grand Pharmaceutical Targeted Psma Radionuclide Drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Grand Pharmaceutical Business Overview
Table 89. Grand Pharmaceutical Recent Developments
Table 90. Global Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Region (2026-2035) & (K MT)
Table 91. Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Region (2026-2035) & (M USD)
Table 92. North America Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 93. North America Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Europe Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 95. Europe Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Region (2026-2035) & (K MT)
Table 97. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 99. South America Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Country (2026-2035) & (Units)
Table 101. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Global Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Type (2026-2035) & (K MT)
Table 103. Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Type (2026-2035) & (M USD)
Table 104. Global Targeted Psma Radionuclide Drug Conjugates Price Forecast by Type (2026-2035) & (USD/KG)
Table 105. Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) Forecast by Application (2026-2035)
Table 106. Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Targeted Psma Radionuclide Drug Conjugates
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD), 2025-2035
Figure 5. Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) (2020-2035)
Figure 6. Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Targeted Psma Radionuclide Drug Conjugates Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Targeted Psma Radionuclide Drug Conjugates Product Life Cycle
Figure 13. Targeted Psma Radionuclide Drug Conjugates Sales Share by Manufacturers in 2025
Figure 14. Global Targeted Psma Radionuclide Drug Conjugates Revenue Share by Manufacturers in 2025
Figure 15. Targeted Psma Radionuclide Drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Targeted Psma Radionuclide Drug Conjugates Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Targeted Psma Radionuclide Drug Conjugates Revenue in 2025
Figure 18. Industry Chain Map of Targeted Psma Radionuclide Drug Conjugates
Figure 19. Global Targeted Psma Radionuclide Drug Conjugates Market PEST Analysis
Figure 20. Global Targeted Psma Radionuclide Drug Conjugates Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Type
Figure 27. Sales Market Share of Targeted Psma Radionuclide Drug Conjugates by Type (2020-2025)
Figure 28. Sales Market Share of Targeted Psma Radionuclide Drug Conjugates by Type in 2025
Figure 29. Market Share of Targeted Psma Radionuclide Drug Conjugates by Type (2020-2025)
Figure 30. Market Share of Targeted Psma Radionuclide Drug Conjugates by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Application
Figure 33. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Application (2020-2025)
Figure 34. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Application in 2025
Figure 35. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Application (2020-2025)
Figure 36. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Application in 2025
Figure 37. Global Targeted Psma Radionuclide Drug Conjugates Sales Growth Rate by Application (2020-2025)
Figure 38. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Region (2020-2025)
Figure 39. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region (2020-2025)
Figure 40. North America Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Country in 2024
Figure 43. North America Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Targeted Psma Radionuclide Drug Conjugates Market Size by Country in 2024
Figure 45. U.S. Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Targeted Psma Radionuclide Drug Conjugates Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Targeted Psma Radionuclide Drug Conjugates Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Targeted Psma Radionuclide Drug Conjugates Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Country in 2024
Figure 53. Europe Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Targeted Psma Radionuclide Drug Conjugates Market Size by Country in 2024
Figure 55. Germany Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Region in 2024
Figure 67. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Market Size by Region in 2024
Figure 68. China Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (K MT)
Figure 79. South America Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Country in 2024
Figure 80. South America Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (M USD)
Figure 81. South America Targeted Psma Radionuclide Drug Conjugates Market Size by Country in 2024
Figure 82. Brazil Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Market Size by Region in 2024
Figure 92. Saudi Arabia Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Targeted Psma Radionuclide Drug Conjugates Production Market Share by Region (2020-2025)
Figure 103. North America Targeted Psma Radionuclide Drug Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Targeted Psma Radionuclide Drug Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Targeted Psma Radionuclide Drug Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 106. China Targeted Psma Radionuclide Drug Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Targeted Psma Radionuclide Drug Conjugates Market Share Forecast by Type (2026-2035)
Figure 111. Global Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Application (2026-2035)
Figure 112. Global Targeted Psma Radionuclide Drug Conjugates Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Targeted Psma Radionuclide Drug Conjugates
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD), 2025-2035
Figure 5. Global Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) (2020-2035)
Figure 6. Global Targeted Psma Radionuclide Drug Conjugates Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Targeted Psma Radionuclide Drug Conjugates Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Targeted Psma Radionuclide Drug Conjugates Product Life Cycle
Figure 13. Targeted Psma Radionuclide Drug Conjugates Sales Share by Manufacturers in 2025
Figure 14. Global Targeted Psma Radionuclide Drug Conjugates Revenue Share by Manufacturers in 2025
Figure 15. Targeted Psma Radionuclide Drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Targeted Psma Radionuclide Drug Conjugates Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Targeted Psma Radionuclide Drug Conjugates Revenue in 2025
Figure 18. Industry Chain Map of Targeted Psma Radionuclide Drug Conjugates
Figure 19. Global Targeted Psma Radionuclide Drug Conjugates Market PEST Analysis
Figure 20. Global Targeted Psma Radionuclide Drug Conjugates Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Type
Figure 27. Sales Market Share of Targeted Psma Radionuclide Drug Conjugates by Type (2020-2025)
Figure 28. Sales Market Share of Targeted Psma Radionuclide Drug Conjugates by Type in 2025
Figure 29. Market Share of Targeted Psma Radionuclide Drug Conjugates by Type (2020-2025)
Figure 30. Market Share of Targeted Psma Radionuclide Drug Conjugates by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Application
Figure 33. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Application (2020-2025)
Figure 34. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Application in 2025
Figure 35. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Application (2020-2025)
Figure 36. Global Targeted Psma Radionuclide Drug Conjugates Market Share by Application in 2025
Figure 37. Global Targeted Psma Radionuclide Drug Conjugates Sales Growth Rate by Application (2020-2025)
Figure 38. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Region (2020-2025)
Figure 39. Global Targeted Psma Radionuclide Drug Conjugates Market Size by Region (2020-2025)
Figure 40. North America Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Country in 2024
Figure 43. North America Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Targeted Psma Radionuclide Drug Conjugates Market Size by Country in 2024
Figure 45. U.S. Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Targeted Psma Radionuclide Drug Conjugates Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Targeted Psma Radionuclide Drug Conjugates Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Targeted Psma Radionuclide Drug Conjugates Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Targeted Psma Radionuclide Drug Conjugates Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Country in 2024
Figure 53. Europe Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Targeted Psma Radionuclide Drug Conjugates Market Size by Country in 2024
Figure 55. Germany Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Region in 2024
Figure 67. Asia Pacific Targeted Psma Radionuclide Drug Conjugates Market Size by Region in 2024
Figure 68. China Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (K MT)
Figure 79. South America Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Country in 2024
Figure 80. South America Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (M USD)
Figure 81. South America Targeted Psma Radionuclide Drug Conjugates Market Size by Country in 2024
Figure 82. Brazil Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Targeted Psma Radionuclide Drug Conjugates Market Size by Region in 2024
Figure 92. Saudi Arabia Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Targeted Psma Radionuclide Drug Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Targeted Psma Radionuclide Drug Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Targeted Psma Radionuclide Drug Conjugates Production Market Share by Region (2020-2025)
Figure 103. North America Targeted Psma Radionuclide Drug Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Targeted Psma Radionuclide Drug Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Targeted Psma Radionuclide Drug Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 106. China Targeted Psma Radionuclide Drug Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Targeted Psma Radionuclide Drug Conjugates Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Targeted Psma Radionuclide Drug Conjugates Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Targeted Psma Radionuclide Drug Conjugates Market Share Forecast by Type (2026-2035)
Figure 111. Global Targeted Psma Radionuclide Drug Conjugates Sales Forecast by Application (2026-2035)
Figure 112. Global Targeted Psma Radionuclide Drug Conjugates Market Share Forecast by Application (2026-2035)
